Comparison of three commercial knowledge bases for detection of drug-drug interactions in clinical decision support
Authors:
Open Access
- 22 February 2017
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of the American Medical Informatics Association
- Vol. 24 (4) , 806-812
Abstract
Objective: To compare 3 commercial knowledge bases (KBs) used for detection and avoidance of potential drug-drug interactions (DDIs) in clinical practice. Methods: Drugs in the DDI tables from First DataBank (FDB), Micromedex, and Multum were mapped to RxNorm. The KBs were compared at the clinical drug, ingredient, and DDI rule levels. The KBs were evaluated against a reference list of highly significant DDIs from the Office of the National Coordinator for Health Information Technology (ONC). The KBs and the ONC list were applied to a prescription data set to simulate their use in clinical decision support. Results: The KBs contained 1.6 million (FDB), 4.5 million (Micromedex), and 4.8 million (Multum) clinical drug pairs. Altogether, there were 8.6 million unique pairs, of which 79% were found only in 1 KB and 5% in all 3 KBs. However, there was generally more agreement than disagreement in the severity rankings, especially in the contraindicated category. The KBs covered 99.8–99.9% of the alerts of the ONC list and would have generated 25 (FDB), 145 (Micromedex), and 84 (Multum) alerts per 1000 prescriptions. Conclusion: The commercial KBs differ considerably in size and quantity of alerts generated. There is less variability in severity ranking of DDIs than suggested by previous studies. All KBs provide very good coverage of the ONC list. More work is needed to standardize the editorial policies and evidence for inclusion of DDIs to reduce variation among knowledge sources and improve relevance. Some DDIs considered contraindicated in all 3 KBs might be possible candidates to add to the ONC list.Keywords
Funding Information
- National Library of Medicine
- National Institutes of Health
This publication has 30 references indexed in Scilit:
- Normalized names for clinical drugs: RxNorm at 6 yearsJournal of the American Medical Informatics Association, 2011
- Towards Meaningful Medication-Related Clinical Decision Support: Recommendations for an Initial ImplementationApplied Clinical Informatics, 2011
- Drug-Drug Interactions in Cardiac and Cardiothoracic Intensive Care UnitsDrug Safety, 2010
- Black Box Warning Contraindicated Comedications: Concordance Among Three Major Drug Interaction Screening ProgramsAnnals of Pharmacotherapy, 2010
- The state of the art in clinical knowledge management: An inventory of tools and techniquesInternational Journal of Medical Informatics, 2010
- Evaluation of accuracy of drug interaction alerts triggered by two electronic medical record systems in primary healthcareHealth Informatics Journal, 2007
- Comparative assessment of four drug interaction compendiaBritish Journal of Clinical Pharmacology, 2006
- Assessment of potential drug–drug interactions with a prescription claims databaseAmerican Journal of Health-System Pharmacy, 2005
- Clinical Relevance of Drug-Drug InteractionsDrug Safety, 2005
- Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ, 2004